To provide you with the best experience, our websites uses features that are not supported by your current browser. For the best experience on Childrenshospitals.org, please open this site in a different browser such as Google Chrome
Children's Hospital Association sent a comment letter to the Energy and Commerce Committee Chair, Cathy McMorris Rodgers, on the discussion draft of the Stop Drug Shortages Act.
Our response calls on Congress to prioritize the unique needs of children when addressing the 340B program, 503B compounding facilities and additional authorities for the Food and Drug Administration.
The 340B program supports children’s hospitals in their mission to serve low-income and underinsured children regardless of their insurance status.
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
CHA submitted a response to the bicameral drug shortages request for information (RFI) to highlight pediatric health care needs.
